ArticleBMC cancer2023
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
Jian He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBMC cancer2023
Jian He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.